Home

ROBERT F APPLE

CIK 1054942 · President and CEO · last filed 2026-07-08

ROBERT F APPLE is a President and CEO who has filed 60 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for KZIA, was dated Jul 8, 2026. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.24M

Companies

3

Total Filings

60

Lifetime Open-Market Net

-$5.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KZIA Director — $13.04 — $0 1 2026-07-08
ANTARES PHARMA, INC. (ATRS) Delisted President & CEO 2,488,360 $5.59 $13.91M -$5.72M 44 2022-03-04
AIS Executive Vice President & CFO 285,231 $70.97 $20.24M $0 14 2012-05-21

Recent Filings

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 KZIA Grant (A) — $0 EDGAR
2022-05-26 — Disp (D) −2,862,459 -$16.03M
2022-03-04 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +49,119 -$143.2K EDGAR
2022-02-18 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +42,611 -$125.5K EDGAR
2021-06-14 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +149,660 $658.5K EDGAR
2021-06-10 ANTARES PHARMA, INC. (ATRS) Delisted Tax (F) −44,223 -$194.1K EDGAR
2021-03-03 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +86,433 -$298.5K EDGAR
2021-02-19 ANTARES PHARMA, INC. (ATRS) Delisted Mixed −90,395 -$2.80M EDGAR
2021-02-10 ANTARES PHARMA, INC. (ATRS) Delisted Mixed — -$191.7K EDGAR
2020-06-15 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +362,038 $986.3K EDGAR
Showing 1–10 of 60
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.